Upper respiratory tract infections
such as tonsillitis, sinusitis, otitis media due to Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pyogenes.
Lower respiratory tract infections
such as acute bacterial exacerbations of chronic bronchitis, lobar and bronchopneumonia due to Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis.
Genito-urinary tract infections
such as urethritis, cystitis, pyelonephritis and female genital infections due to Enterobacteriaceae (especially E.coli), Staphylococcus saprophyticus, and Enterococcus species.
Skin and soft tissue infections
caused by Staphylococcus aureus, Streptococcus pyogenes and Bacteroides species.
Bone and joint infections
such as osteomyelitis caused by Staphylococcus aureus, which is prolonged treatment may be needed.
such as septic abortion, puerperal sepsis, intra-abdominal sepsis.
- Amoxicillin 125 mg
- Clavulanic Acid 31.25 mg
Children Age <12 Years or Weight <40 kg
Otitis media, sinusitis, lower respiratory tract infections and urinary tract infections:
40/10-60/15 mg/kg body weight per day in divided doses every 8 hours.
Skin and soft tissue infections, tonsillitis:
20/5-40/10 mg/kg body weight per day in divided doses every 8 hours.
To minimize potential gastrointestinal intolerance and to optimized the absorption, it is recommended to take amoxicillin-clavulanate combination at the start of a meal. Treatment should not be extended beyond 14 days without review.
Patients with Renal Impairment
Children <12 years of age OR weight <40 kg
Mild impairment (creatinine clearance >30 ml/minute):
No change in dosage.
Moderate impairment (creatinine clearance 10-30 ml/minute):
15/3.75 mg/kg in divided doses every 12 hours.
Severe impairment (creatinine clearance ˂10 ml/minute):
15/3.75 mg/kg as a single dose daily.
15/3.75 mg/kg as a single dose. Patients should receive an additional dose both during and at the end of dialysis.